Literature DB >> 27905822

Uterine cancer, mutational phenotype, and the era of immune checkpoint blockade.

Dana M Roque1, Alessandro D Santin2.   

Abstract

Entities:  

Keywords:  Uterine cancer; immune checkpoint blockade; mutational phenotype

Mesh：

Year:  2016        PMID： 27905822      PMCID： PMC5537620          DOI： 10.1080/1744666X.2017.1266938

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  25 in total

1.  The relation between funding by the National Institutes of Health and the burden of disease.

Authors:  C P Gross; G F Anderson; N R Powe
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab.

Authors:  Alessandro D Santin; Stefania Bellone; Natalia Buza; Jungmin Choi; Peter E Schwartz; Joseph Schlessinger; Richard P Lifton
Journal:  Clin Cancer Res       Date:  2016-08-02       Impact factor: 12.531

3.  Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.

Authors:  Siming Zhao; Murim Choi; John D Overton; Stefania Bellone; Dana M Roque; Emiliano Cocco; Federica Guzzo; Diana P English; Joyce Varughese; Sara Gasparrini; Ileana Bortolomai; Natalia Buza; Pei Hui; Maysa Abu-Khalaf; Antonella Ravaggi; Eliana Bignotti; Elisabetta Bandiera; Chiara Romani; Paola Todeschini; Renata Tassi; Laura Zanotti; Luisa Carrara; Sergio Pecorelli; Dan-Arin Silasi; Elena Ratner; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Amy L Stiegler; Shrikant Mane; Titus J Boggon; Joseph Schlessinger; Richard P Lifton; Alessandro D Santin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

Review 4.  Microsatellite Instability as a Biomarker for PD-1 Blockade.

Authors:  Jonathan C Dudley; Ming-Tseh Lin; Dung T Le; James R Eshleman
Journal:  Clin Cancer Res       Date:  2016-02-15       Impact factor: 12.531

Review 5.  Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis.

Authors:  Yoon Young Choi; Jung Min Bae; Ji Yeong An; In Gyu Kwon; In Cho; Hyun Beak Shin; Tanaka Eiji; Mohammad Aburahmah; Hyung-Il Kim; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh
Journal:  J Surg Oncol       Date:  2014-04-15       Impact factor: 3.454

Review 6.  Prognostic and predictive significance of MSI in stages II/III colon cancer.

Authors:  Zacharenia Saridaki; John Souglakos; Vassilis Georgoulias
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

7.  Wilms' tumor 1 (WT1) peptide immunotherapy for gynecological malignancy.

Authors:  Satoshi Ohno; Satoru Kyo; Subaru Myojo; Satoshi Dohi; Junko Ishizaki; Ken-Ichi Miyamoto; Satoshi Morita; Jun-Ichi Sakamoto; Takayuki Enomoto; Tadashi Kimura; Yoshihiro Oka; Akihiro Tsuboi; Haruo Sugiyama; Masaki Inoue
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

8.  Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.

Authors:  Anke Vanderstraeten; Catherine Luyten; Godelieve Verbist; Sandra Tuyaerts; Frederic Amant
Journal:  Cancer Immunol Immunother       Date:  2014-06       Impact factor: 6.968

Review 9.  Immunotherapy in endometrial cancer - an evolving therapeutic paradigm.

Authors:  Teresa C Longoria; Ramez N Eskander
Journal:  Gynecol Oncol Res Pract       Date:  2015-12-02

10.  Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer.

Authors:  A D Santin; S Bellone; A Ravaggi; J J Roman; S Pecorelli; G P Parham; M J Cannon
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.